Clincosm LogoSign in Get a demo

ATAC: Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography

Sponsor
The Cleveland Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT01746537
Collaborator
(none)
1,500
Enrollment
1
Location
132
Duration (Months)
11.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A prospective, observational, case series investigating the feasibility of utilizing OCT scans of the anterior chamber of eyes with uveitis.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Automated Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
    Study Start Date :
    Jun 1, 2012
    Anticipated Primary Completion Date :
    Jun 1, 2023
    Anticipated Study Completion Date :
    Jun 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Use the OCT to objectively image and grade the degree of anterior chamber inflammation in eyes with inactive and active uveitis. [one year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All patients presenting to Cole Eye Institute with uveitis.
    Exclusion Criteria:

    • Inability to provide informed consent, including non-English speaking and cognitively/mentally impaired.

    • Severe corneal opacities preventing imaging of anterior chamber

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cole Eye Institute Cleveland Ohio United States 44195

    Sponsors and Collaborators

    • The Cleveland Clinic

    Investigators

    • Principal Investigator: Sunil K Srivastva, MD, The Cleveland Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sunil Srivastava, Medical Doctor, The Cleveland Clinic
    ClinicalTrials.gov Identifier:
    NCT01746537
    Other Study ID Numbers:
    • 12-612
    First Posted:
    Dec 11, 2012
    Last Update Posted:
    Apr 28, 2022
    Last Verified:
    Apr 1, 2022
    Additional relevant MeSH terms:
    Uveitis
    Inflammation

    Study Results

    No Results Posted as of Apr 28, 2022